Iterum Therapeutics PLC Stock Ownership - Who owns Iterum Therapeutics?

Insider buying vs selling

Have Iterum Therapeutics PLC insiders been buying or selling?
Corey N. FishmanChief Executive Officer2023-03-115,683$0.96
Judith M. MatthewsChief Financial Officer2023-03-112,883$0.96
Sailaja PuttaguntaChief Medical Officer2022-12-023,365$1.32

1 of 1

ITRM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ITRM insiders and whales buy or sell their stock.

ITRM Shareholders

What type of owners hold Iterum Therapeutics PLC stock?
Ra Capital Management LP89.35%11,651,597$8.39MInsider
Brenton Karl Ahrens13.29%1,733,580$1.25MInsider
Canaan X LP13.29%1,733,170$1.25MInsider
James Healy13.29%1,732,668$1.25MInsider
Patrick J. Heron11.87%1,547,322$1.11MInsider
Vijay K. Lathi11.17%1,456,303$1.05MInsider
Sofinnova Venture Partners Ix LP9.41%1,226,514$883.09kInsider
Shahzad Malik6.66%868,161$625.08kInsider
Apollon Wealth Management LLC1.53%200,000$144.00kInstitution
Ronald Hunt0.81%105,953$76.29kInsider

1 of 3

ITRM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ITRM1.95%98.05%Net Selling
TMBR0.21%99.79%Net Buying
FNCH1.28%98.72%Net Selling

Iterum Therapeutics Stock Ownership FAQ

Who owns Iterum Therapeutics?

Iterum Therapeutics (NASDAQ: ITRM) is owned by 3.39% institutional shareholders, 170.80% Iterum Therapeutics insiders, and 0.00% retail investors. Ra Capital Management LP is the largest individual Iterum Therapeutics shareholder, owning 11.65M shares representing 89.35% of the company. Ra Capital Management LP's Iterum Therapeutics shares are currently valued at $8.39M.

If you're new to stock investing, here's how to buy Iterum Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.